Oval Park Capital is one of the only VC firms in the U.S. Southeast that exclusively backs deeptech and hardtech startups in non-FDA physical and industrial technologies, deliberately positioning itself between legacy life sciences VCs and newer software-only VCs. The firm targets the midsection of the deep technology and intellectual property spectrum—disruptive but commercially nearer-term technologies that are protectable yet have reduced time, cost, and risk to commercialization—while focusing on capital-starved industrial sectors like advanced manufacturing, materials, climate, robotics, and water/energy infrastructure in overlooked ecosystems.